Matthew Ellsworth, DPM
Podiatrist · Ashland, KYNPI 1124387618
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 68.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $416 and has fallen 63.4% since, to $152 in 2023.
Across 60 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$672
- Integra Lifesciences Corporation$117
- Stryker$107
- Organogenesis Inc.$20
- Zimvie Inc.$18
- AbbVie$17
- plus $33 from 2 others
What the payments were for
- Food & beverage$94996%
- Education$364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 47 | $672 |
| Integra Lifesciences Corporation | 6 | $117 |
| Stryker | 2 | $107 |
| Organogenesis Inc. | 1 | $20 |
| Zimvie Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $16 |
How this compares
$984 in reported general payments places this provider in the 60th percentile of 54 podiatrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 75 | $1,251 |
| CiclopiroxCiclopirox Olamine | 62 | $1,201 |
| Gabapentin | 118 | $859 |
| Ammonium Lactate | 57 | $625 |
| Doxycycline Hyclate | 66 | $366 |
| Terbinafine Hcl | 24 | $313 |
| Diclofenac Sodium | 25 | $211 |
| Mupirocin | 22 | $180 |
| Prednisone | 38 | $126 |
| Triamcinolone Acetonide | 13 | $78 |
| Meloxicam | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Ashland
- Michelle MurrayAshland$485
- Christopher MooreAshland$54
- Lauren Triplett-SchweickartAshland$20
- Thomas ChildressLouisville$283K
- Joshua CogerLouisville$132K
- David SmithHopkinsville$66K
- Matthew FeltnerCampbellsville$38K
- Zachery WeyandtLouisville$37K
- Robert HerbstFlorence$24K
- Michael AllenLexington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.